| Name of Trial | Description |
R-3750 | A single and repeat dosing study to characterize the safety and tolerability of R-3750 orally delivered to patients with mild to moderate Ulcerative Colitis (UC). |
MK-7240 ( or ) | A phase three study to evaluate the safety and tolerability of MK-7240 for patients who have moderate to severely active ulcerative colitis (UC) or Crohn’s disease (CD). |
Please contact Keanna Capener for more information:
Email: keanna.capener@cuanschutz.edu
Phone: 303-724-4420